B
BioMark Diagnostics Inc
CNSX:BUX
BioMark Diagnostics Inc
CNSX:BUX
Price:
0.6
CAD
-3.23%
Market Closed
Market Cap:
CA$63.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
CA |
|
E
|
Elron Ventures Ltd
TASE:ELRN
|
IL |
Balance Sheet
Balance Sheet Decomposition
BioMark Diagnostics Inc
BioMark Diagnostics Inc
Balance Sheet Decomposition is not available for
BioMark Diagnostics Inc
BioMark Diagnostics Inc
Balance Sheet
BioMark Diagnostics Inc
BioMark Diagnostics Inc
Currency: CAD
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-85%
|
0
+17%
|
0
+31%
|
0
-33%
|
1
+1 742%
|
1
+50%
|
1
+54%
|
1
-50%
|
1
+49%
|
3
+188%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+614%
|
1
+88%
|
1
-14%
|
1
+32%
|
1
-14%
|
1
-4%
|
2
+104%
|
2
-11%
|
2
-10%
|
1
-18%
|
|
| Equity | ||||||||||||
| Common Stock |
2
|
3
|
3
|
4
|
4
|
5
|
7
|
7
|
8
|
10
|
14
|
|
| Retained Earnings |
3
|
4
|
5
|
6
|
6
|
8
|
9
|
9
|
12
|
13
|
16
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
4
|
|
| Total Equity |
0
N/A
|
1
N/A
|
1
-92%
|
1
+15%
|
1
-35%
|
0
+64%
|
0
+82%
|
1
-704%
|
1
-81%
|
1
+47%
|
2
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-85%
|
0
+17%
|
0
+31%
|
0
-33%
|
1
+1 742%
|
1
+50%
|
1
+54%
|
1
-50%
|
1
+49%
|
3
+188%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
49
|
53
|
54
|
63
|
65
|
72
|
77
|
78
|
83
|
91
|
105
|
|
Switch to:
Switch to:
See Also
Discover More
